(Q39227230)

10 September 2017

title

Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL. (English)

1 reference

10 September 2017

C Maurer

1

1 reference

10 September 2017

P Langerbeins

2

1 reference

10 September 2017

J Bahlo

3

1 reference

10 September 2017

P Cramer

4

1 reference

10 September 2017

A M Fink

5

1 reference

10 September 2017

N Pflug

6

1 reference

10 September 2017

A Engelke

7

1 reference

10 September 2017

J von Tresckow

8

1 reference

10 September 2017

G Kovacs

9

1 reference

10 September 2017

S Stilgenbauer

10

1 reference

10 September 2017

C-M Wendtner

11

1 reference

10 September 2017

L Müller

12

1 reference

10 September 2017

M Ritgen

13

1 reference

10 September 2017

T Seiler

14

1 reference

10 September 2017

K Fischer

15

1 reference

10 September 2017

M Hallek

16

1 reference

10 September 2017

B Eichhorst

17

1 reference

10 September 2017

publication date

2 May 2016

1 reference

10 September 2017

1 reference

10 September 2017

volume

30

1 reference

10 September 2017

issue

10

1 reference

10 September 2017

page(s)

2019-2025

1 reference

Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Risk of second cancer after chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Second cancers in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Long-term cancer risk of immunosuppressive regimens after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Malignancies induced by chlorambucil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Immunosuppressive effects of pentostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Hodgkin's disease variant of Richter's syndrome. Report of eight cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

B-cell chronic lymphocytic leukemia followed by high grade T-cell lymphoma. An unusual variant of Richter's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Richter syndrome: biology, incidence, and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Comorbidity and functional status are independent in older cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Richter's syndrome--the downside of fludarabine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Association of Cancer With AIDS-Related Immunosuppression in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma).

21 January 2018

1 reference

12 December 2020

Biweekly chlorambucil treatment of lymphocytic lymphoma

1 reference

12 December 2020

Immunosuppression and cancer.

1 reference

12 December 2020

Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases

1 reference

12 December 2020

Solid tumors after chronic lymphocytic leukemia

1 reference

12 December 2020

Hairy cell transformation of a B-cell chronic lymphocytic leukemia: a morphological, cytochemical, phenotypic and molecular study

1 reference

12 December 2020

Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia

1 reference

12 December 2020

Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies

1 reference

12 December 2020

T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy

1 reference

12 December 2020

Small B-cell lymphoid neoplasms with coexisting T-cell lymphomas

1 reference

12 December 2020

Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias

1 reference

12 December 2020

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

1 reference

12 December 2020

Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological, and molecular study.

1 reference

12 December 2020

Generalized Reticular Cell Sarcoma of Lymph Nodes Associated with Lymphatic Leukemia.

1 reference

12 December 2020

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

1 reference

12 December 2020

Emergence of a B-cell lymphoblastic lymphoma in a patient with B-cell chronic lymphocytic leukemia: evidence for the single-cell origin of the two tumors

1 reference

12 December 2020

Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.

1 reference

12 December 2020

Carcinogenic potency of alkylating agents in rodents and humans

1 reference

12 December 2020

Richter's syndrome: a report on 39 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.113

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/LEU.2016.113

1 reference

10 September 2017

1 reference